skip to main content

LABA without ICS in asthma — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateRespiratory TherapeuticsLABA without ICS in asthmaGPhC CRA

A prescription for salmeterol inhaler is presented for an asthma patient who has no inhaled corticosteroid on the PMR. They have had recent night symptoms. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Query the prescription before supply

LABA monotherapy in asthma is unsafe because it can mask worsening inflammation and increase risk. The pharmacist should confirm that inhaled corticosteroid therapy is in place. In this scenario, the correct option is query the prescription before supply. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.

Reference: BNF; NICE CKS